Astrocytoma

About
Mappings

OncoTree: Astrocytoma (oncotree:ASTR)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) IDH1 p.R132C Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132G Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132H Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132L Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132S Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172K Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172M Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172G Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172S Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172W Astrocytoma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132C Astrocytoma Vorasidenib HC
Sensitivity (+) IDH1 p.R132G Astrocytoma Vorasidenib HC
Sensitivity (+) IDH1 p.R132H Astrocytoma Vorasidenib HC
Sensitivity (+) IDH1 p.R132L Astrocytoma Vorasidenib HC
Sensitivity (+) IDH1 p.R132S Astrocytoma Vorasidenib HC
Sensitivity (+) IDH2 p.R172K Astrocytoma Vorasidenib HC
Sensitivity (+) IDH2 p.R172M Astrocytoma Vorasidenib HC
Sensitivity (+) IDH2 p.R172G Astrocytoma Vorasidenib HC
Sensitivity (+) IDH2 p.R172S Astrocytoma Vorasidenib HC
Sensitivity (+) IDH2 p.R172W Astrocytoma Vorasidenib HC